Mirum Pharmaceuticals (MIRM) Other Non-Current Assets (2019 - 2026)

Mirum Pharmaceuticals' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $16.2 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 195.6% year-over-year to $16.2 million; the TTM figure through Mar 2026 stood at $16.2 million (up 195.6% YoY), while the FY2025 annual figure was $1.5 million, up 248.71% from the prior year.
• Other Non-Current Assets was $16.2 million for Q1 2026 at Mirum Pharmaceuticals, up from $1.5 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $16.2 million in Q1 2026 to a low of $425000.0 in Q4 2024.
• Historically, Other Non-Current Assets has averaged $3.0 million across 5 years, with a median of $1.6 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets soared 256.29% in 2024, then slumped 91.08% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $1.4 million in 2022, then climbed by 9.26% to $1.5 million in 2023, then plunged by 71.85% to $425000.0 in 2024, then jumped by 248.71% to $1.5 million in 2025, then soared by 991.84% to $16.2 million in 2026.
• The last three Other Non-Current Assets figures came in at $16.2 million (Q1 2026), $1.5 million (Q4 2025), and $480000.0 (Q3 2025), per Business Quant data.